Recent Finacing
Recent Raise
Opus Genetics develops AAV-based gene therapies for inherited retinal diseases, advancing a Phase 1/2 LCA5 program and preclinical RHO and MERTK retinal replacement programs from UPenn, based in NC.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
